StockWatch
·
Misc Health and Biotechnology Services
InvestmentJun 4, 2026, 08:32 AM

NewGenIvf boosts K25.ai stake to 6% with additional $4M investment

AI Summary

NewGenIvf Group Ltd exercised its top-up option to acquire an additional 4% equity in K25.ai, increasing its total holding to 6%. This US$4 million investment comprises US$2 million in cash/digital assets and 1.5 million newly issued Class A ordinary shares. Concurrently, NewGenIvf is adopting a Digital Asset Treasury strategy and plans to invite K25.ai's CEO and co-founders to its Board of Directors. The company's 6% stake in K25.ai is now valued at approximately US$6 million, and it retains an option to acquire a further 4%.

Key Highlights

  • NewGenIvf increased its equity stake in K25.ai by 4% to a total of 6%.
  • The additional investment is US$4,000,000, split between cash/digital assets and shares.
  • US$2,000,000 is payable in cash or digital assets, with US$300,000 paid as a deposit.
  • 1,500,000 newly issued Class A ordinary shares of NewGenIvf comprise the remaining consideration.
  • NewGenIvf's 6% stake in K25.ai is valued at approximately US$6,000,000.
  • Company adopted a Digital Asset Treasury strategy for reserve accumulation and strategic allocation.
  • K25.ai's CEO Andy Cheung and co-founders will be invited to NewGenIvf's Board.
  • NewGenIvf retains an option to acquire a further 4% of K25.ai.